Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Volume of Liposomal Bupivacaine in Adductor Canal Block for Knee Surgery
NCT06942689Phase 4Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in postoperative pain, sponsored by Nanjing First Hospital. Started Jun 2025; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06942689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06942689.